Trial shows first head‑to‑head superiority in joint endpoints for an approved PsA biologic
Author: Clinical Editor
Baxdrostat delivers clinically meaningful blood pressure reductions in phase 3 BaxHTN trial
UK government plans to increase the price the NHS pays for drugs will face a legal challenge from […]
Regulations for handling “vexatious” patients must be toughened to protect GPs and their staff against the growing threat […]
Davies provides a salutary reminder of the harm that can be caused by the diagnoses we make.1 Most […]
A new outbreak of Ebola virus disease in central Africa, caused by the rare Bundibugyo version of the […]
Screening with a PSA (prostate specific antigen) blood test reduces prostate cancer deaths by two for every 1000 […]
Parsortix platform to support minimally invasive analysis across various cancer trials
Data suggests microbiome co-therapy may help overcome resistance to anti‑PD‑1 treatment
Polyendocrine metabolic ovarian syndrome (PMOS), formerly polycystic ovary syndrome (PCOS), is one of the commonest endocrine disorders in […]